Spielholz C, Schlichter D, Wicks W D
Department of Biochemistry, University of Tennessee, Knoxville 37996-0840.
Mol Endocrinol. 1988 Apr;2(4):344-9. doi: 10.1210/mend-2-4-344.
Cyclic AMP has been shown to stimulate synthesis of tyrosine aminotransferase (L-tyrosine:2-oxoglutarate aminotransferase, EC 2.6.1.5) by increasing the amount of its mRNA through an increase in initiation of transcription. However, cAMP also has posttranscriptional effects on the enzyme's synthesis, as evidenced by the 4- to 5-fold enhanced decline seen when cultured hepatoma cells are exposed to cAMP and transcription is inhibited. As a direct test of the possibility that cAMP exerts this effect by destabilizing the mRNA for tyrosine aminotransferase, we analyzed the rate of decay of the mRNA using the transcriptional inhibitor 5,6-dichlororibofuranosylbenzimidazole, Northern blot analysis, and an internal standard consisting of prelabeled rRNA. It was found that the half-life of the mRNA (2.0 +/- 0.2 h) was not changed by treatment of cultured hepatoma cells under conditions which increase intracellular cAMP levels. These mRNA half-life values were not significantly different from the decline in the rate of synthesis of the enzyme after induction in dexamethasone-treated cells. We conclude that cAMP does not affect the stability of the mRNA for tyrosine aminotransferase and discuss other possible explanations for the paradoxical effect of cAMP on deinduction of this enzyme.
环磷酸腺苷(cAMP)已被证明可通过增加转录起始来提高酪氨酸转氨酶(L-酪氨酸:2-酮戊二酸转氨酶,EC 2.6.1.5)的mRNA量,从而刺激其合成。然而,cAMP对该酶的合成也有转录后效应,当培养的肝癌细胞暴露于cAMP且转录受到抑制时,酶合成的下降增强了4至5倍就证明了这一点。作为对cAMP通过使酪氨酸转氨酶的mRNA不稳定来发挥这种效应这一可能性的直接测试,我们使用转录抑制剂5,6-二氯呋喃核糖基苯并咪唑、Northern印迹分析以及由预标记的rRNA组成的内标来分析mRNA的衰变率。结果发现,在增加细胞内cAMP水平的条件下处理培养的肝癌细胞,mRNA的半衰期(2.0±0.2小时)没有改变。这些mRNA半衰期值与地塞米松处理的细胞诱导后酶合成速率的下降没有显著差异。我们得出结论,cAMP不影响酪氨酸转氨酶mRNA的稳定性,并讨论了cAMP对该酶去诱导的矛盾效应的其他可能解释。